Work

A Phase II study of axitinib (AG-013736), a potent inhibitor of VEGFRs, in patients with advanced thyroid cancer

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.5529

Authors: S. Kim, L. S. Rosen, E. E. Cohen, R. B. Cohen, A. Forastiere, A. M. Silva, K. F. Liau, R. L. Archer, P. Bycott, E. E. Vokes

Institutions: Fox Chase Cancer Center, Johns Hopkins University, University of Chicago Medical Center

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3011452829

Cites:

Cited by: 17

Related to: 10